A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study

Background and study aim: Endoscopy with duodenal biopsy is often performed in order to assess histological recovery in patients with celiac disease who are on a gluten-free diet. Use of the ”immersion” technique during upper endoscopy allows visualization of duodenal villi or detection of total villous atrophy. In this two-center study, we investigated the accuracy of the immersion technique in predicting histological recovery in patients on a gluten-free diet whose initial diagnosis of celiac disease had been made on the basis of total villous atrophy.

Patients and methods: The immersion technique was performed in 62 patients with celiac disease who were being treated and who had been referred for follow-up (26 patients at the Rome center and 36 patients at the Vicenza center). All these patients had an initial diagnosis based on positive antibodies and biopsy-proved duodenal total villous atrophy. At the follow-up examination, the duodenal villi were re-evaluated as present or absent by one endoscopist at each center, and the results were compared with the histology.

Results: At the follow-up endoscopy, the duodenal villi were found to be present in 51 patients and absent in 11. The sensitivity, specificity, positive predictive value, and negative predictive value of the immersion technique for detecting the presence or absence of villi were all 100 %.

Conclusions: This study demonstrated the feasiblity and the high level of accuracy of the immersion technique in predicting the histological recovery of duodenal villi in patients with celiac disease who are following a gluten-free diet. An endoscopy-based approach that avoids the need for biopsy could be useful for monitoring the dietary adherence and/or response of patients with an initial diagnosis of celiac disease based on total villous atrophy.

References

• 1 Pietzak M M. Follow-up of patients with celiac disease: achieving compliance with treatment.  Gastroenterology. 2005;  128 (4 Suppl 1) S135-S141
• 2 Burgin-Wolff A, Dahlbom I, Hadziselimovic F. et al . Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease.  Scand J Gastroentrol. 2002;  37 685-691
• 3 Tursi A, Brandimarte G, Giorgetti G M. Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease.  J Clin Gastroentrol. 2003;  37 387-391
• 4 Collin P, Kaukinen K, Vogelsang H. et al . Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study.  Eur J Gastroenterol Hepatol. 2005;  17 85-91
• 5 National Institutes of Health .Consensus development conference statement. Celiac disease. June 28-30 2004. [Accessed 7 Nov 2005]. http://consensus.nih.gov/2004/2004celiacDisease118html. htm
• 6 Lee S k, Lo W, Memeo L. et al . Duodenal histology in patients with celiac disease after treatment with a gluten-free diet.  Gastrointest Endosc. 2003;  57 187-191
• 7 Brocchi E, Tomassetti P, Misitano B. et al . Endoscopic markers in adult coeliac disease.  Dig Liver Dis. 2002;  34 177-182
• 8 Gasbarrini A, Ojetti V, Cuoco L. et al . Lack of endoscopic visualization of intestinal villi with the ”immersion technique” in overt atrophic celiac disease.  Gastrointest Endosc. 2003;  57 348-351
• 9 Cammarota G, Martino A, Pirozzi G A. et al . Direct visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation study.  Gastrointest Endosc. 2004;  60 732-738
• 10 Cammarota G, Pirozzi G, Martino A. et al . Reliability of the ”immersion technique“ during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia.  Gastrointest Endosc. 2004;  60 223-228
• 11 Cammarota G, Cesaro P, Martino A. et al . High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease.  Aliment Pharmacol Ther. 2006;  23 61-69
• 12 Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists.  Eur J Gastroenterol Hepatol. 1999;  11 1185-1194
• 13 American Gastroenterological Association medical position statement: celiac sprue.  Gastroenterology. 2001;  120 1522-1525
• 14 Cammarota G, Gasbarrini A, Gasbarrini G. No more biopsy in the diagnostic work-up of celiac disease.  Gastrointest Endosc. 2005;  62 119-121
• 15 Catassi C, Bearzi I, Holmes G K. Association of celiac disease and intestinal lymphomas and other cancers.  Gastroenterology. 2005;  128 (4 Suppl 1) S79-S86
• 16 Mitka M. Higher profile needed for celiac disease.  JAMA. 2004;  292 913-914
• 17 Tomei E, Diacinti D, Marini M. et al . Abdominal CT findings may suggest coeliac disease.  Dig Liver Dis. 2005;  37 402-406
• 18 Petroniene R, Dubcenco E, Baker J P. et al . Given capsule endoscopy in celiac disease: evaluation of diagnostic accuracy and interobserver agreement.  Am J Gastroenterol. 2005;  100 685-694
• 19 Harewood G C, Murray J A. Diagnostic approach to a patient with suspected celiac disease: a cost analysis.  Dig Dis Sci. 2001;  46 2510-2514
• 20 Dell’Aquila P, Pietrini L, Barone M. et al . Small intestinal contrast ultrasonography-based scoring system: a promising approach for the diagnosis and follow-up of celiac disease.  J Clin Gastroenterol. 2005;  39 591-595
• 21 Quine M A, Bell G D, McCloy R F. et al . Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England.  Br J Surg. 1995;  82 530-533